| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.094 | 0.7 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |